VEEVA SYSTEMS INC
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Veeva Systems (VEEV) launched Falcon Safety, a product to streamline adverse event management for biopharma companies. It integrates with existing safety systems and is set for early access in November 2026. VEEV's stock closed at $279.23, down 2.26%.
Veeva Systems (VEEV) launched Veeva Falcon Safety, a product to streamline adverse event intake and case processing for biopharma companies. It will work with E2B-compliant systems like Oracle Argus and ArisGlobal LifeSphere. Falcon Safety is part of Veeva AI and is planned for early adopter availability in November 2026. The company serves over 1,500 customers in the life sciences industry.
Schwenger Thomas D. (Pres. & Chief Customer Officer) sold 10,000 shares of VEEVA SYSTEMS INC (VEEV) at $281.33 ($2.81M total) on 2026-08-27 under a Rule 10b5-1 trading plan.
Over the past 7 days, alphai's AI scored 39 news stories mentioning VEEV (VEEVA SYSTEMS INC). Coverage has skewed bullish: 35 bullish, 3 neutral, and 1 bearish.
Recent VEEV coverage spans earnings, technology and financial news.
In the last 30 days, VEEV insiders filed 4 SEC Form 4 transactions — no purchases and 4 sales ($11.8M). The most active reporter was Schwenger Thomas D., Pres. & Chief Customer Officer, with 4 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
The launch expands Veeva's safety suite and may boost demand from life‑science customers.
The launch may boost VEEV's top‑line by attracting new customers and cross‑selling to existing Veeva Safety users.
Insider sale may signal negative sentiment, potentially pressuring the stock short term.
Strong top‑line growth and upgraded guidance suggest upside potential; buyback indicates confidence and may support price.
Long position performed strongly.
alphai scores every news story that mentions VEEV with an AI model for sentiment and relevance, and aggregates insider trades from VEEVA SYSTEMS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Veeva Systems (VEEV) launched Falcon Safety, a product to streamline adverse event management for biopharma companies. It integrates with existing safety systems and is set for early access in November 2026. VEEV's stock closed at $279.23, down 2.26%.
2 min readVeeva Systems (VEEV) launched Veeva Falcon Safety, a product to streamline adverse event intake and case processing for biopharma companies. It will work with E2B-compliant systems like Oracle Argus and ArisGlobal LifeSphere. Falcon Safety is part of Veeva AI and is planned for early adopter availability in November 2026. The company serves over 1,500 customers in the life sciences industry.
1 min readSchwenger Thomas D. (Pres. & Chief Customer Officer) sold 10,000 shares of VEEVA SYSTEMS INC (VEEV) at $281.33 ($2.81M total) on 2026-08-27 under a Rule 10b5-1 trading plan.
1 min readVeeva Systems (VEEV) reported Q2 2027 revenues of $928.0 million, up 18% YoY, driven by growth in commercial and R&D segments. Subscription revenues rose 16% to $766.8 million. Non-GAAP operating income was $415.9 million, with a 44.8% margin. The company raised FY 2027 revenue guidance to $3.682B-$3.687B and EPS guidance to $9.21. Management highlighted strong adoption of Vault CRM and Data Cloud solutions, with 12 top 20 biopharmas committed to Vault CRM. Risks include the launch of the new Fa
3 min readMichael Burry, known for his 'Big Short' bet, disclosed August trades including long positions in MercadoLibre (MELI), Zoetis (ZTS), Lululemon (LULU), and Molina Healthcare (MOH), and short positions in Palantir (PLTR), Nvidia (NVDA), and others. Nine of his 17 long holdings rose, with Veeva (VEEV) up 35.8%, while his short bets faced pressure as AI stocks rallied, with Palantir up 51.4%. Burry adjusted his portfolio, raising cash and managing risk.
3 min readVeeva Systems (VEEV) shares rose 9% after-hours on August 30, 2026, following stronger-than-expected Q2 results and raised full-year guidance. GF Value™ estimates VEEV as 5.0% undervalued at $276.69, with a GF Score™ of 95. Subscription revenues grew 16% to $766.8M. Insiders sold $18.1M in shares, while 8 gurus hold the stock, with 7 adding positions.
2 min readVeeva Systems (VEEV) reported Q2 revenue of $927.96M and net income of $273.43M, raising full-year guidance and announcing new AI CRM wins with Biogen and Regeneron. The company projects $4.7B revenue and $1.4B earnings by 2029, though some analysts forecast lower figures.
3 min readStocks rallied after Nvidia reported Q2 revenue of $96.22B, above estimates, and projected 70% fiscal 2028 revenue growth. AI and chipmaker stocks surged, with NVDA up 7%. CRM jumped 18% after raising Q3 revenue guidance. OKTA and CRWD also rose on strong earnings and forecasts. VEEV, NTNX, and DG rose on positive updates, while WEN, HRL, HPQ, and DLTR fell on negative news.
3 min readMichael Burry reduced his stake in Veeva Systems (VEEV) after a near-100% gain, citing its higher price. He also trimmed PayPal (PYPL) ahead of a failed acquisition, planning to add more if it falls to the mid-$40s. VEEV and PYPL stocks showed mixed after-hours trading. Burry still holds smaller stakes in both, believing in their long-term value.
2 min readNvidia (NVDA) reported strong Q2 earnings and raised Q3 revenue guidance to $108B, driving its stock up 9% and boosting tech sector gains. Nasdaq, S&P 500, and Dow closed higher. Other notable movers include Okta (OKTA) +29%, Salesforce (CRM) +23%, and CrowdStrike (CRWD) +20%. Corporate profits surged $400B in Q2, partly due to $71B in tariff refunds.
3 min read
